Co-Authors
This is a "connection" page, showing publications co-authored by BARBARA JANE O'BRIEN and RIVKAH COLEN.
Connection Strength
0.558
-
Post-treatment imaging changes in primary brain tumors. Curr Oncol Rep. 2014; 16(8):397.
Score: 0.476
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.046
-
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494.
Score: 0.035